Doerschug K - Search Results

1

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK. Stevens SM, et al. Among authors: doerschug k. Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 2. Chest. 2021. PMID: 34352278

2

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.

Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Jimenez D, Le Gal G, Rali P, Wells P. Moores LK, et al. Among authors: doerschug k. Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2. Chest. 2020. PMID: 32502594 Free PMC article.

3

Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK. Stevens SM, et al. Among authors: doerschug k. Chest. 2021 Dec;160(6):2247-2259. doi: 10.1016/j.chest.2021.07.056. Epub 2021 Aug 2. Chest. 2021. PMID: 34352279

4

Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report.

Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Iaccarino J, Jimenez D, LeGal G, Rali P, Wells P. Moores LK, et al. Among authors: doerschug k. Chest. 2022 Jul;162(1):213-225. doi: 10.1016/j.chest.2022.02.006. Epub 2022 Feb 12. Chest. 2022. PMID: 35167861 Free PMC article.

5

Point: Should antipyretic therapy be given routinely to febrile patients in septic shock? Yes.

Mohr NM, Doerschug KC. Mohr NM, et al. Chest. 2013 Oct;144(4):1096-1098. doi: 10.1378/chest.13-0916. Chest. 2013. PMID: 24081339 No abstract available.

6

Checklists for Safety During ICU Intubations: The Details Matter.

Doerschug KC, Niven AS. Doerschug KC, et al. Chest. 2018 Jun;153(6):1505-1506. doi: 10.1016/j.chest.2018.02.036. Chest. 2018. PMID: 29884259 No abstract available.

7

COUNTERPOINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? No.

Jimenez D, Rali P, Doerschug K. Jimenez D, et al. Among authors: doerschug k. Chest. 2022 Jun;161(6):1448-1451. doi: 10.1016/j.chest.2022.01.037. Epub 2022 Mar 15. Chest. 2022. PMID: 35550714 Free PMC article. No abstract available.

8

Rebuttal From Drs Mohr and Doerschug.

Mohr NM, Doerschug KC. Mohr NM, et al. Chest. 2013 Oct;144(4):1101-1102. doi: 10.1378/chest.13-0917. Epub 2013 Oct 12. Chest. 2013. PMID: 29852548 No abstract available.

9

In Replay: Fever Control and Sepsis Mortality.

Mohr NM, Doerschug KC. Mohr NM, et al. Chest. 2014 Mar;145(3):667. doi: 10.1378/chest.13-2809. Chest. 2014. PMID: 27845648 No abstract available.

10

Counterpoint: Should an anesthesiologist be the specialist of choice in managing the difficult airway in the ICU? Not necessarily.

Doerschug KC. Doerschug KC. Chest. 2012 Dec;142(6):1375-1377. doi: 10.1378/chest.12-2196. Chest. 2012. PMID: 23208330 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters